A private equity panel offered perspectives from investors who are fueling the next generation of security innovations. The inaugural Access Control/Mergers & Acquisitions (AC/MA) Summit in New York ...
Lausanne, Switzerland, October 5, 2023 – AC Immune SA, a clinical-stage biopharmaceutical company pioneering precision medicine for neurodegenerative diseases, today announced that Company Management ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results